Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00889265 · ClinicalTrials.gov registry record · NA
CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation
A NA study, sponsored by Zimmer Biomet.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT00889265 is a NA study that has completed, run by Zimmer Biomet. The registered enrollment target is 51 participants.
The verdict
NCT00889265, a NA study, has completed, sponsored by Zimmer Biomet.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
This is a prospective, multi-center study to evaluate the use of CopiOs Pericardium Membrane, a bovine xenograft, with use of Puros Cancellous Particulate Allograft, for the augmentation of localized alveolar ridge defects on either the maxilla or mandible.
Interventions
- DEVICE CopiOs Pericardium Membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00889265
The ClinicalTrials.gov registry entry for NCT00889265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CopiOs Pericardium Membrane is the first listed.
NCT00889265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00889265 about?
NCT00889265 is a clinical study titled "CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation". This is a prospective, multi-center study to evaluate the use of CopiOs Pericardium Membrane, a bovine xenograft, with use of Puros Cancellous Particulate Allograft, for the augmentation of localized alveolar ridge defects on either the maxilla or mandible.
What is the current status of trial NCT00889265?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2009-06. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00889265?
The interventions under investigation include: CopiOs Pericardium Membrane (DEVICE).
Who is sponsoring clinical trial NCT00889265?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.